NASDAQ
28.08.26 | 22:00
7,040 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | What Shattuck Labs Stock Topped the Market on Monday | 3 | The Motley Fool | ||
| 12.08. | H.C. Wainwright cuts Shattuck Labs stock price target on trial expansion | 1 | Investing.com | ||
| 12.08. | H.C. Wainwright senkt Kursziel für Shattuck Labs wegen Studienerweiterung | 3 | Investing.com Deutsch | ||
| 11.08. | Shattuck Labs, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 11.08. | Shattuck Labs Aktie gibt nach Quartalsbericht nach | 6 | Investing.com Deutsch | ||
| 11.08. | Shattuck Labs, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 11.08. | Shattuck Labs, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| SHATTUCK LABS Aktie jetzt für 0€ handeln | |||||
| 11.08. | Shattuck Labs GAAP EPS of -$0.12 in-line | 3 | Seeking Alpha | ||
| 11.08. | Shattuck Labs, Inc.: Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights | 474 | GlobeNewswire (Europe) | - Phase 1 clinical trial results for SL-325 demonstrated a favorable safety profile, a potentially best-in-mechanism immunogenicity profile, and durable DR3 blockade of TL1A binding, potentially enabling... ► Artikel lesen | |
| 25.07. | Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday | 1 | The Motley Fool | ||
| 24.07. | This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday | 1 | Benzinga.com | ||
| 24.07. | JPMorgan reiterates Shattuck Labs stock rating on DR3 program | 4 | Investing.com | ||
| 11.06. | Shattuck Labs, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | Shattuck Labs drops 6%, prices $75M share raise at $4 per share | 1 | Seeking Alpha | ||
| 10.06. | Shattuck Labs Announces Pricing Of 10.88 Mln Shares Public Offering At $4/Shr | 307 | AFX News | WASHINGTON (dpa-AFX) - Shattuck Labs, Inc. (STTK), a clinical-stage biotechnology company, on Wednesday revealed the pricing of its earlier announced public offering of 10.88 million shares... ► Artikel lesen | |
| 10.06. | Shattuck Labs prices $75M public offering at $4 per share | 1 | Investing.com | ||
| 10.06. | Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering | 1 | GlobeNewswire (USA) | ||
| 09.06. | Shattuck Labs commences public offering of common stock | 2 | Investing.com | ||
| 09.06. | Shattuck Labs launches proposed public offering of common stock | 1 | Seeking Alpha | ||
| 09.06. | Shattuck Labs, Inc. Announces Proposed Public Offering | 1 | GlobeNewswire (USA) |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 2,798 | +0,76 % | Katalysator voraus: Valneva (ISIN: FR0004056851) setzt auf Q3-Shigella-Daten | ||
| VIVORYON THERAPEUTICS | 1,125 | -0,88 % | Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026 | Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
Halle (Saale) / Munich, Germany, August 18, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7)... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,349 | +4,18 % | Breaking News! NurExone Biologic plant großes Börsen-Upgrade! | ||
| SAREPTA THERAPEUTICS | 18,240 | +1,33 % | Biotech-Player: Zelltherapie als Comeback-Story im Milliardenmarkt. Neue Ideen nach Corona von BioNTech, Qiagen und Biotech AG | ||
| ARROWHEAD PHARMACEUTICALS | 73,36 | -3,30 % | Could Arrowhead Pharmaceuticals (ARWR)'s Plozasiran Become the Catalyst for a Major Stock Re-rating? | ||
| ONCO-INNOVATIONS | 0,340 | 0,00 % | Onco-Innovations Limited: Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program | CALGARY, AB / ACCESS Newswire / August 19, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered... ► Artikel lesen | |
| REVOLUTION MEDICINES | 180,25 | +0,42 % | Revolution Medicines (RVMD) Made Pancreatic-Cancer History. At $47B Valuation, the Market Already Assumed It | ||
| TRAWS PHARMA | 0,590 | 0,00 % | Traws Pharma, Inc.: Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights | Advancing tivoxavir marboxil toward MHRA resubmission in Q3 2026 with a revised toxicology package, supporting initiation of the Phase 2a human influenza Challenge studyCompleted the April 2026 private... ► Artikel lesen | |
| VERASTEM | 6,280 | +0,71 % | Mizuho lowers Verastem stock price target on valuation to $13 | ||
| TRINITY BIOTECH | 9,700 | +0,31 % | Trinity Biotech expands PrePsia patent portfolio to nine patents | ||
| ZAI LAB LTD ADR | 23,000 | +1,77 % | ZAI LAB (09688): 2026 INTERIM REPORT | ||
| VOYAGER THERAPEUTICS | 2,990 | -2,03 % | H.C. Wainwright reiterates Voyager Therapeutics stock rating at buy | ||
| XBIOTECH | 1,928 | 0,00 % | XBiotech Inc.: XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis | IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment
AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:... ► Artikel lesen | |
| TVARDI THERAPEUTICS | 1,580 | 0,00 % | Tvardi Therapeutics to Participate in Upcoming Investor Events | ||
| VANDA PHARMACEUTICALS | 4,710 | +3,24 % | Vanda gets EU orphan designation for psoriasis drug imsidolimab |
SHATTUCK LABS INC gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 7,040 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHATTUCK LABS INC finden Sie auf Wallstreet Online.